March 16, 2023
Join Us in Chicago at AUA 2023!
LynxDx and the Windy City will blow you away with the next generation of prostate cancer risk prediction.
MyProstateScore 2.0 (MPS2) is a urine test designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7) by analyzing a comprehensive array of 18 unique gene transcripts.
Come see us at the American Urological Association’s annual meeting April 28-May 1, 2023 and discover how a 30-second urine sample can give you personalized insights to guide your patients.